The Food and Drug Administration on Monday for the first time gave a green light to a game-based therapeutic: a video game meant to be prescribed to kids with ADHD.
The game, known as EndeavorRx and developed by Boston-based Akili Interactive Labs, can now be marketed as a way to improve attention function in kids with ADHD as measured by computerized testing. Physicians can prescribe it to children between the ages of 8 and 12 who have an ADHD diagnosis and have demonstrated an issue with attention.
The FDA’s move is a landmark decision in the emerging digital therapeutics sector: In addition to being the first game to be marketed as a therapy for any type of condition, EndeavorRx is the first digital therapeutic meant to improve symptoms associated with ADHD, the FDA’s announcement said…The game was born in the University of California, San Francisco lab of neuroscientist Adam Gazzaley, and was licensed out by Akili, which polished and tested the game in clinical trials. Akili spent the past two years waiting on a regulatory decision from the FDA.
Decades from now when our augmented brains have enhanced our cognitive function and transformed nearly every aspect of our lives, many of us will look back and wonder why we didn’t do more to prepare for these inevitable changes. Government leaders may grapple with the runaway effects of AI and brain enhancement on geopolitics. Companies that fail to incorporate neurotechnologies and BCI into their operational flow could lose significant market share and be forced to scramble in an attempt to regain a foothold in an industry they once dominated.
Workers who don’t heed the warnings to re-skill or upskill may find themselves out of a job as entire industries disappear. Graduating college students may discover their field of study is no longer relevant in the business world, leaving them unprepared for the changing job market. Tech innovators could be caught up in fierce competition to snap up employees from a very limited talent pool, driving up the cost of innovation and hampering its development. And everyday citizens may be wrestling with the unexpected consequences of unintentionally giving away the rights to their neural data.
Rest assured, it doesn’t have to be this way. [Read more…] about Fast Forward to 2040: How to prepare for the new era in brain enhancement that will change the way we think, work, and heal
We are proud to announce these 40 confirmed Summit Speakers, Chairs and Judges at the 2017 SharpBrains Virtual Summit on December 5–7th. What an incredible brain trust shaping the future of brain health and enhancement!
Here are just a few:
Dr. Adam Gazzaley, Professor of Neurology and Founding Director of Neuroscape at UCSF
Dr. Gazzaley is a faculty member in the Neurology, Physiology and Psychiatry departments, and Director of a cognitive neuroscience laboratory conducting research on the neural mechanisms of attention and memory. Dr. Gazzaley is also co-founder and Chief Science Advisor of Akili Interactive Labs, a company developing therapeutic video games, and co-founder and Chief Scientist of JAZZ Venture Partners, a venture capital firm investing in experiential technology to improve human performance.
Dr. Adam Haim, Chief of the Clinical Trials Operations and
Alexandra Morehouse, CMO of Banner Health
Alexandra M. Morehouse is Senior Vice President & Chief Marketing Officer for Banner Health, one of the nation’s largest nonprofit health systems. Prior to Banner Health, she was the Vice President of Brand Management at Kaiser Permanente, and CMO of AAA. She has served on the boards of the Harvard Business School Community Partners, SnapFish, Yerba Buena Center for the Arts, ODC Dance, and UC Davis.
Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization (NIO)
Dr. Fenney runs the Neurotechnology Industry Organization, a global trade association representing companies involved in neuroscience, brain research institutes and patient advocacy groups. Prior to NIO, Alison was Manager of Industry Relations at the Ontario Brain Institute (OBI) in Canada, and also worked in Equity Research at Bloom Burton & Co.
Álvaro Fernández, CEO and Editor-in-Chief of SharpBrains
Álvaro Fernández, a member of the World Economic Forum’s Council on the Future of Human Enhancement, runs SharpBrains, an independent market research firm tracking health and performance applications of brain science. Mr. Fernandez is the co-author of “The SharpBrains Guide to Brain Fitness: How to Optimize Brain Health and Performance at Any Age”, and the Editor-in-chief of SharpBrains’ market report on Pervasive Neurotechnology.
For more, here you can Meet 40 Experts and Innovators at the frontier of Brain Health & Enhancement.
I feel it is critical that scientists make an effort to translate their research discoveries into a format that is understandable and meaningful to the general public. They should also, at least on occasion, step beyond detailed descriptions of laboratory results and speculate on how their findings inform the bigger picture and impact people’s lives. This has never been more important than it is it right now, in this time of dramatically reduced science funding. In the PBS-sponsored special, The Distracted Mind, I try to accomplish this by integrating material from dozens of [Read more…] about Raising awareness about the distracted mind (PBS special)
As an active participant in the OpenViBE project (a software platform to design, test and use Brain-Computer Interfaces), in scientific as well as technical capacities, I have long been focused on ways to process, analyze and put brain signals to practical use. When I started reading on the subject of brain fitness a few years ago, I recognized the potential to enhance a variety of brain training approaches, from meditation to cognitive training, by deploying [Read more…] about Brain fitness meets HRV and EEG biometrics and neuroinformatics
We are excited to invite you to the first virtual, global SharpBrains Summit (January 18–20th, 2010). The SharpBrains Summit will feature a dream team of over 25 speakers who are leaders in industry and research from 7 countries, to discuss emerging research, tools and best practices for cognitive health and performance. This inaugural event will expose health and insurance providers, developers, innovators at Fortune 500 companies, investors and researchers, to the opportunities, partnerships, trends, and standards of the rapidly evolving cognitive fitness field.
Learn more and register Here today, at discounted early-bird rates, to receive these benefits:
- Learn: Full access to all Conference live sessions, and Downloadable Recordings and Handouts
- See: latest technologies and products during Expo Day
- Connect and Discuss: become a member of the SharpBrains Network for Brain Fitness Innovation (members-only LinkedIn Group) through the end of 2010, access online chats during the summit, meet other registrants in your city
- Understand the Big Picture: access 10 Research Executive Briefs prepared by leading scientists
On top of those early-bird discounts, we offer an additional 15% discount for SharpBrains readers who want Regular Admission. Discount code: sharp2010. You can register Here.
Monday, January 18th, 2010:
(Preliminary schedule, US Pacific Time)
8–9.15am. Cognition & Neuroplasticity: The New Healthcare Frontier
- Alvaro Fernandez, SharpBrains
- David Whitehouse, OptumHealth Behavioral Solutions
- William Reichman, Baycrest
- P Murali Doraiswamy, Duke University
9.30–11am. Tools for Safer Driving: The Opportunity with Teenagers and Adults
- Steven Aldrich, Posit Science
- Shlomo Breznitz, CogniFit
- Jerri Edwards, University of South Florida
- Peter Christianson, Young Drivers of Canada
Noon‑1.30pm. Baby Boomers and Beyond: Maintaining Cognitive Vitality
- Kunal Sarkar, Lumos Labs
- Elizabeth Zelinski, USC Davis School of Gerontology [Read more…] about Invitation to SharpBrains Summit — Technology for Cognitive Health and Performance